Abstract
Sarcoidosis is a systemic disorder of uncertain etiology characterized by noncaseating granulomatous inflammation. The disease often involves the heart on autopsy, but the antemortem diagnosis of cardiac sarcoidosis is frequently missed. Cardiac involvement usually includes granulomatous inflammation or fibrosis of the myocardium, conduction system, or pericardium. We now describe a case of epicardial coronary involvement by sarcoidosis, where the diagnosis was made by surgical biopsy of the coronary artery in an African American man presenting with acute coronary syndrome and recurrent symptomatic restenosis following coronary intervention. The case extends the spectrum of common cardiac syndromes that cardiac sarcoidosis can masquerade as and highlights the importance of maintaining a high index of suspicion for early recognition and instituting specific treatment that might improve prognosis. A review of the literature also suggests the need for improvement in diagnostic approaches and prospective clinical trials to establish the best management strategy for this disease. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (2.5 MB).
References
- 1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997; 336: 1224–1234. [DOI] [PubMed] [Google Scholar]
- 2. Bernstein M, Konzlemann FW, Sidlick DM. Boeck's sarcoid: report of a case with visceral involvement. Ann Intern Med. 1929; 44: 721–734. [Google Scholar]
- 3. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995; 119: 167–172. [PubMed] [Google Scholar]
- 4. Longcope WT, Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore). 1952; 31: 1–132. [PubMed] [Google Scholar]
- 5. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977; 63: 86–108. [DOI] [PubMed] [Google Scholar]
- 6. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976; 278: 455–469. [DOI] [PubMed] [Google Scholar]
- 7. Cooper LT Jr. Cardiac sarcoidosis In: Cooper LT, Jr, ed. Myocarditis: From Bench to Bedside. Totowa, NJ: Humana Press; 2003:; 421–436. [Google Scholar]
- 8. Wait JL, Movahed A. Anginal chest pain in sarcoidosis. Thorax. 1989; 44: 391–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Treaba DO, Benson MD, Assad LW, Dainauskas JR. Sarcoidosis and immunoglobulin lambda II light‐chain amyloidosis diagnosed after orthotopic heart transplantation: a case report and review of the literature. Mod Pathol. 2005; 18: 451–455. [DOI] [PubMed] [Google Scholar]
- 10. Butany J, Bahl NE, Morales K, et al. The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol. 2006; 15: 222–227. [DOI] [PubMed] [Google Scholar]
- 11. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685–1695. [DOI] [PubMed] [Google Scholar]
- 12. Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002; 347: 5–12. [DOI] [PubMed] [Google Scholar]
- 13. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999; 138: 299–302. [DOI] [PubMed] [Google Scholar]
- 14. Schulz‐Menger J, Wassmuth R, Abdel‐Aty H, et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart. 2006; 92: 399–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Borchert B, Lawrenz T, Bartelsmeier M, Rothemeyer S, Kuhn H, Stellbrink C. Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis. Clin Res Cardiol. 2007; 96: 769–762. [DOI] [PubMed] [Google Scholar]
- 16. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther. 1996; 10: 495–510. [DOI] [PubMed] [Google Scholar]
- 17. Johns CA, Paz H, Kasper EK, Baughman K. Myocardial sarcoidosis: course and management. Sarcoidosis. 1992; 9(suppl 1): 231–236. [Google Scholar]
- 18. Hiramitsu S, Morimoto S, Uemura A, et al. National survey on status of steroid therapy for cardiac sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis. 2005; 22: 210–213. [PubMed] [Google Scholar]
- 19. Takada K, Ina Y, Yamamoto M, Satoh T, Morishita M. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis. 1994; 11: 113–117. [PubMed] [Google Scholar]
- 20. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant. 1987; 6: 244–250. [PubMed] [Google Scholar]
- 21. Rossman MD, Kreider ME. Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc Am Thorac Soc. 2007; 4: 453–456. [DOI] [PubMed] [Google Scholar]